PDS Biotech Provides Business Update and Reports Second Quarter 2021 Financial Results
12 août 2021 07h05 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotechnology to Present Recent Phase 2 Human Clinical Data and On-Going Oncology Programs at Investor Conferences
28 juil. 2021 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., July 28, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotechnology Announces Conference Call and Webcast to Present Second Quarter 2021 Financial Results
26 juil. 2021 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., July 26, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotech to Host Company Conference Call Following Oral Presentation of PDS0101 Data at 2021 ASCO Annual Meeting
24 mai 2021 08h07 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
PDS Biotechnology Appoints Immuno-Oncology Experts Dr. Olivera Finn and Dr. Mark Frohlich to Scientific Advisory Board
18 mai 2021 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 18, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results
13 mai 2021 07h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series
12 mai 2021 08h00 HE
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...